sing of aspirin in the prevention of preeclampsia

Not Applicable

Completed

• Conditions: ??? ???????? ????-??? ???????? ????-??? ???????? ?? ????? ??? ???????; Condition 1: Preeclampsia. Condition 2: preeclampsia.; Gestational [pregnancy-induced] hypertension with significant proteinuria; O14.0,O14.

• Registration Number: IRCT2013072914198N1
• Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Singleton pregnancies at 11-14 weeks and with riskfactors for preeclampsia such as;nulliparous women.

Exclusion criteria;Fetal chromosomal or structural abnormalities,allergy to acetylsalicylic tablets,medical conditions:renal,lupus and coronary artery heart disease,bleeding disorders.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnosis of preeclampsia. Timepoint: 2 month after onset-every 4 week-End of treatment. Method of measurement: Monitor of blood pressure and proteinuria.;Time of onset of preeclampsia. Timepoint: 2 month after onset-every 4 week-End of treatment. Method of measurement: LMP and ultrasound at time of booking.;Criteria of severity of preeclampsia. Timepoint: 2 month after onset-every 4 week-End of treatment. Method of measurement: Monitor for blood pressure and proteinuria and symptoms and signs.

Secondary Outcome Measures

Name	Time	Method
Maternal bleeding that need to transfusion. Timepoint: From delivery for 24 hours after. Method of measurement: Signe and symptoms-decreasing of Hb after delivery-nu.;Intrauterine growth restriction. Timepoint: 2??? ??? ?? ???? ??????-?? 4 ????-????? ??????. Method of measurement: When the fetal weight will below the 10th percentile for gestational in ultrasound and also when the neonatal birth weight will fill bellow the 10th percentile.;Preterm delivery. Timepoint: 2 month after onset-every 4 week-End of treatment. Method of measurement: LMP and ultrasound at time of booking.;Still birth. Timepoint: 2 month after onset-every 4 week-End of treatment. Method of measurement: With FHR monitoring and ultrasound.